---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-004850"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T14:37:10.975361+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioSig Technologies receives Nasdaq bid-price deficiency notice; 180-day cure period until Oct 8, 2025

## Summary
- On April 11, 2025, Nasdaq notified BioSig that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days (until October 8, 2025) to regain compliance by closing at $1.00 or more for at least 10 consecutive days.
- If not cured by October 8, may seek an additional 180-day extension by meeting other listing standards and signaling intent to reverse split.
- Failure to regain compliance could lead to delisting from Nasdaq Capital Market; no immediate impact on trading.
- Stock continues to trade under symbol BSGM while the company addresses the deficiency.

## SEC filing metadata
- accession: 0001641172-25-004850
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/0001641172-25-004850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-004850
- JSON: https://secwatch.observer/filing/0001641172-25-004850.json
- Plain text: https://secwatch.observer/filing/0001641172-25-004850.txt

## Key facts
- Listing & Compliance Notices
  Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: April 11, 2025, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 27, 2025, through April 10, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calenda
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/0001641172-25-004850-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.